newsfilter
← Latest News
GlobeNewswire·

Myriad Commercially Launches Precise MRD with Select Community Oncologists

SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, today announces the launch of the Precise MRD™ (molecular